Sibylla Biotech
PrivateLast Round
Series A
Oct 4, 2022
Total Funding Raised
$22.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sibylla Biotech is a biotechnology company that develops small molecule therapeutics using its proprietary PPI-FIT platform to induce targeted protein degradation by interfering with protein folding pathways.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sibylla Biotech Comparables
Compare Sibylla Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Charm Therapeutics | 83% | |
| Peptone | 83% | |
| SyntheX | 78% | |
Sibylla Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 4, 2022 | ||||
| Seed | Jul 1, 2019 |
Key People
Founding team and executive leadership
Sibylla Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vertis SGR | Series A |
| Seroba Life Sciences | Series A |
| 3B FUTURE Health Fund | Series A |
| Indaco Venture Partners SGR | Series A |
| VI Partners | Series A |
| V-Bio Ventures | Series A |
| Claris Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 82% MoM, reaching 1K.
- Apr 1, 2026
Monthly visitors increased 38% MoM.
Sibylla Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sibylla Biotech's valuation, stock price, and market status.